A number of protein markers of MDS have recently been identified, and it has been reported that the soluble form of vascular endothelial growth factor receptor 1 (sVEGFR-1) is over-expressed in patients with MDS and AML [54]. This evidence concerns the gene FLT1 and myelodysplastic syndrome.